ASO Author Reflections: The Role of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck: Now and into the Future

Affiliations

• ¹ Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia. Mark.pinkham@health.qld.gov.au.
• ² University of Queensland, Brisbane, Australia. Mark.pinkham@health.qld.gov.au.
• ³ School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
• ⁴ Department of Radiation Oncology, Chris O'Brien Lifehouse, Sydney, Australia.
• ⁵ Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
• ⁶ Genesiscare, Mater Hospital, North Sydney, Australia.
• ⁷ Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ⁸ The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VC, Australia.
• ⁹ Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia.
• ¹⁰ Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
• ¹¹ Charles Perkins Centre, The University of Sydney, Sydney, Australia.
• ¹² Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, Australia.
• ¹³ Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia.
• ¹⁴ University of Queensland, Brisbane, Australia.
• ¹⁵ Queensland University of Technology, Brisbane, Australia.
• ¹⁶ Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK.
• ¹⁷ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ¹⁸ Department of Radiation Oncology, MD Anderson Cancer Centre, Houston, TX, USA.
• ¹⁹ ICON Cancer Centre, Revesby, Australia.
• ²⁰ GenesisCare Fraser Coast, Hervey Bay, Australia.